COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...
Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2. The data ...
The Centers for Disease Control and Prevention updated its guidance for the COVID-19 vaccine on Monday, ending months of confusion about the vaccine in Maryland. The new guidance advises people 65 and ...
WASHINGTON D.C. – The Centers for Disease Control and Prevention (CDC) has updated its COVID-19 vaccine guidance, now recommending shots for individuals 65 and older after consulting with a doctor or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results